Clinical Trials Logo

Nipah Virus Infection clinical trials

View clinical trials related to Nipah Virus Infection.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05178901 Completed - Clinical trials for Nipah Virus Infection

A Phase 1 Study to Evaluate Safety & Immunogenicity of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects

Start date: January 10, 2022
Phase: Phase 1
Study type: Interventional

A Phase 1 Study to Evaluate the Safety and Immunogenicity of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects

NCT ID: NCT04199169 Completed - Clinical trials for Nipah Virus Infection

Safety and Immunogenicity of a Nipah Virus Vaccine

Start date: February 18, 2020
Phase: Phase 1
Study type: Interventional

A first-in-human, phase 1 trial is to be conducted in a healthy adult population in the US to assess the safety and immunogenicity of three ascending Nipah vaccine (HeV-sG-V; Hendra virus soluble glycoprotein vaccine) dosages. Different dosing regimens and number of doses will also be explored.